Manager, Contract Development
Regeneron Pharmaceuticals
Summary
The Manager, Contract Development will lead the drafting, negotiation, and maintenance of contract language, templates, and terms and conditions supporting Regeneron’s commercial customer segments, including IDNs, GPOs, hospitals and alternate sites of care, specialty pharmacies, specialty distributors, payers/PBMs, and trade and retail customers. Partnering closely with the Contract Strategy leads, they translate approved contracting strategies into executable, compliant contract language and work across Market Access and Legal to deliver terms that balance commercial objectives, customer value, operational feasibility, and compliance.
Job description
Discover your role:
- Lead the drafting, negotiation, and execution of contract language for assigned institutional and channel customers, translating approved contract strategy into executable terms and conditions.
- Draft, negotiate, and support execution of agreements of standard-to-moderate complexity to support strategy, raising high-value or highly complex agreements to CSOP leadership.
- Apply enterprise-approved templates, standard clauses, and terms and conditions consistently and compliantly across customer segments; flag where new or modified language is needed.
- Develop specific account knowledge and understanding of contractual terms and actual performance for all Institutional customers.
- Support Pricing Committee agenda and materials development within Regeneron as it relates to contract language, terms, and risk positioning.
- Support template governance, clause maintenance, and risk identification for assigned agreements.
- Support ongoing development, maintenance, and version control of contract templates and clause libraries under the governance framework established by Contract Development leadership, partnering with Legal.
- Identify and document legal, financial, and operational risk within contract language; bring up material risk to leadership with a recommended position.
- Synthesize cross-functional input from Contract Strategy, Contract Management, Rebate Operations, Account Management, and Government Pricing into clear risk summaries for decision-making.
- Monitor the impact of evolving healthcare laws and regulations on assigned contract terms and flag template and policy implications.
- Partner cross-functionally to ensure contract language is strategically aligned, operationally feasible, and compliant.
- Translate product, pricing, and customer strategy into accurate, executable contract language, partnering with CSOP.
- Coordinate across CSOP to confirm operational feasibility and execution of contract language.
Requirements
- Bachelor’s degree with a focus in Marketing, Business Administration, Science, Pharmacy, or Accounting/Finance preferred; paralegal degree or certification a plus.
- Solid understanding of the U.S. Healthcare environment required.
- 6+ years of experience in US Pharma / biotech / healthcare industry, with experience in institutional or channel contracting, contract development / agreement drafting, pricing, and/or market access preferred.
- Working knowledge of contract drafting, agreement language, and industry-standard contracting terms, and of GPO, IDN, hospital, alternate-site-of-care, specialty pharmacy, specialty distributor, payer/PBM, trade, and/or retail customers.
- Advanced computer skills using MS Office (Word, Excel, Outlook, Visio/PowerPoint); ability to prepare, analyze, and interpret data and reporting (internal and external) required; strong communication both oral and written, with the ability to effectively present information and respond to questions.
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.